Evaluation Onset Time of DWP450-004 and Safety in Moderate-severe Glabellar Lines
NCT02568150
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate-severe Glabellar Lines
Interventions
BIOLOGICAL:
Single group, open-label
Sponsor
Daewoong Pharmaceutical Co. LTD.